ClinVar Miner

Submissions for variant NM_007294.3(BRCA1):c.124A>C (p.Ile42Leu) (rs80357163)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000482375 SCV000571897 uncertain significance not provided 2016-10-05 criteria provided, single submitter clinical testing This variant is denoted BRCA1 c.124A>C at the cDNA level, p.Ile42Leu (I42L) at the protein level, and results in the change of an Isoleucine to a Leucine (ATA>CTA). Using alternate nomenclature, this variant would be defined as BRCA1 243A>C. This variant was observed in a pediatric patient with T-cell acute lymphoblastic leukemia (Zhang 2015). BRCA1 Ile42Leu was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, suggesting it is not a common benign variant in these populations. Since Isoleucine and Leucine share similar properties, this is considered a conservative amino acid substitution. BRCA1 Ile42Leu occurs at a position that is conserved in mammals and is located within the RING domain as well as the BRD7 and BARD1 binding domains (Narod, 2004, Borg 2010, Harte 2010, Paul 2014). In silico analyses are inconsistent regarding the effect this variant may have on protein structure and function. Based on currently available evidence, it is unclear whether BRCA1 Ile42Leu is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.